Hemant Shah

A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

Frederik Nevens, Pietro Andreoné, G. Mazzella et al. · New England Journal of Medicine · 2016 · 1.1K citations · Full text

Factors Associated With Incomplete Colonoscopy: A Population-Based Study

Hemant Shah, Lawrence Paszat, Refik Saskin et al. · Gastroenterology · 2007 · 352 citations · Full text

Gastroenterology, Outcomes Research, Incomplete Colonoscopy +4

Toronto HCC risk index: A validated scoring system to predict 10-year risk of HCC in patients with cirrhosis

Suraj Sharma, Matthew Kowgier, Bettina E. Hansen et al. · Journal of Hepatology · 2017 · 207 citations · Full text

Validated Scoring System, Hepatology, Clinical Epidemiology +9

Benign Tumors of the Tracheobronchial Tree

Hemant Shah, Louise Garbe, Eric S. Nussbaum et al. · CHEST Journal · 1995 · 190 citations

Surgical Pathology, Benign Tumors, Thoracic Surgery +3

Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study

David Jones, Pol Boudes, Mark G. Swain et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 181 citations

Molecular Pharmacology, Selective Ppar-δ Agonist, Hepatology +11